{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T17:06:13Z","timestamp":1794416773349,"version":"4.9.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T00:00:00Z","timestamp":1559088000000},"content-version":"vor","delay-in-days":393,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.jacc.2018.03.490","type":"journal-article","created":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T14:38:10Z","timestamp":1526913490000},"page":"2405-2414","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":301,"title":["Inhibition of Interleukin-1\u03b2 by Canakinumab and Cardiovascular Outcomes in Patients With Chronic\u00a0Kidney Disease"],"prefix":"10.1016","volume":"71","author":[{"given":"Paul M","family":"Ridker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean G.","family":"MacFadyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Glynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Koenig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Libby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan M.","family":"Everett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Lefkowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Thuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan H.","family":"Cornel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2018.03.490_bib1","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2018.03.490_bib2","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1056\/NEJMoa041365","article-title":"Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction","volume":"351","author":"Anavekar","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2018.03.490_bib3","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/S0140-6736(12)61350-6","article-title":"Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis","volume":"380","author":"Fox","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2018.03.490_bib4","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(12)60572-8","article-title":"Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study","volume":"380","author":"Tonelli","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2018.03.490_bib5","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/ki.2011.178","article-title":"Novel inflammatory mechanisms of accelerated atherosclerosis in kidney disease","volume":"80","author":"Swaminathan","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacc.2018.03.490_bib6","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1681\/ASN.2010080798","article-title":"The inflammasome in kidney disease","volume":"22","author":"Anders","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jacc.2018.03.490_bib7","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/01.mnh.0000444814.49755.90","article-title":"The emerging role of the inflammasome in kidney diseases","volume":"23","author":"Chang","year":"2014","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.jacc.2018.03.490_bib8","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/nep.12785","article-title":"The NLRP3 inflammasome in kidney disease and autoimmunity","volume":"21","author":"Hutton","year":"2016","journal-title":"Nephrology"},{"key":"10.1016\/j.jacc.2018.03.490_bib9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/CIRCRESAHA.115.306656","article-title":"From C-reactive protein to interleukin-6 to interleukin-1: moving upstream to identify novel targets for atheroprotection","volume":"118","author":"Ridker","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2018.03.490_bib10","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1016\/j.jacc.2017.09.028","article-title":"Interleukin-1 beta as a target for atherosclerosis therapy. Biological basis of CANTOS and beyond","volume":"70","author":"Libby","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2018.03.490_bib11","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1161\/01.CIR.101.15.1767","article-title":"Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men","volume":"101","author":"Ridker","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2018.03.490_bib12","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2018.03.490_bib13","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/eurheartj\/eht367","article-title":"Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis","volume":"35","author":"Kaptoge","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2018.03.490_bib14","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0272-6386(00)70200-9","article-title":"C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients","volume":"35","author":"Yeun","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jacc.2018.03.490_bib15","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/ndt\/17.9.1684","article-title":"Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment","volume":"17","author":"Pecoits-Filho","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jacc.2018.03.490_bib16","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/ki.2009.503","article-title":"Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease","volume":"77","author":"Barreto","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacc.2018.03.490_bib17","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1053\/j.ajkd.2009.06.029","article-title":"Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus","volume":"54","author":"Krane","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jacc.2018.03.490_bib18","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0272-6386(97)90495-9","article-title":"Interleukin-1 receptor antagonist modulates the progression of a spontaneously occurring IgA nephropathy in mice","volume":"30","author":"Chen","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jacc.2018.03.490_bib19","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1681\/ASN.V94614","article-title":"Role of IL-1 in renal ischemic reperfusion injury","volume":"9","author":"Haq","year":"1998","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jacc.2018.03.490_bib20","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1097\/01.CCM.0000233878.36340.10","article-title":"Interleukin-1-dependent sequential chemokine expression and inflammatory cell infiltration in ischemia-reperfusion injury","volume":"34","author":"Furuichi","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jacc.2018.03.490_bib21","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1097\/01.ASN.0000115704.86897.F4","article-title":"Contributions of IL-1beta and IL-1alpha to crescentic glomerulonephritis in mice","volume":"15","author":"Timoshanko","year":"2004","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jacc.2018.03.490_bib22","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1681\/ASN.2005040393","article-title":"Linking metabolism and immunology: diabetic nephropathy is an inflammatory disease","volume":"16","author":"Tuttle","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jacc.2018.03.490_bib23","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.kint.2017.08.013","article-title":"A\u00a0molecular morphometric approach to diabetic kidney disease can link structure to function and outcome","volume":"93","author":"Nair","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacc.2018.03.490_bib24","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/ki.2014.271","article-title":"NLRP3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy","volume":"87","author":"Shahzad","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacc.2018.03.490_bib25","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2018.03.490_bib26","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(17)32814-3","article-title":"Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomized controlled trial","volume":"391","author":"Ridker","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2018.03.490_bib27","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"German Diabetes and Dialysis Study Investigators. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2018.03.490_bib28","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","article-title":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis","volume":"360","author":"Fellstr\u00f6m","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2018.03.490_bib29","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ki.2008.484","article-title":"Effect of atorvastatin on inflammation and outcome in patients with type 2 diabetes mellitus on hemodialysis","volume":"74","author":"Krane","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacc.2018.03.490_bib30","first-page":"828","article-title":"The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction","volume":"38","author":"van Hout","year":"2017","journal-title":"Eur Heart J"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109718342712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109718342712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:15:25Z","timestamp":1760015725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109718342712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":30,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0735109718342712"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2018.03.490","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of Interleukin-1\u03b2 by Canakinumab and Cardiovascular Outcomes in Patients With Chronic\u00a0Kidney Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2018.03.490","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}